Five Key Takeaways From FDA’s CBD Public Meeting

Kelley Drye

With CBD projected to be a $450 Million industry in the coming year, FDA hosted a packed house of industry stakeholders last week in a day-long public meeting that was the kickoff of a discussion to determine whether there is a pathway for CBD in ingestible products such as foods and dietary supplements. See our summary of key themes here and check out this podcast episode to hear five key takeaways.